Trial Profile
A Phase 1/2a Study to Assess the Safety and Efficacy of CKD-516 Tab. in Combination With Irinotecan Inj. in Patients With Previously Treated Advanced Colorectal Cancer
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 13 Apr 2021
Price :
$35
*
At a glance
- Drugs Valecobulin (Primary) ; Irinotecan
- Indications Colorectal cancer
- Focus Adverse reactions
- Sponsors Chong Kun Dang
- 07 Apr 2021 Status has been changed to completed.
- 07 Apr 2021 Results published in the Investigational New Drugs
- 30 Oct 2019 Results of phase I part of this study (n=39) presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2019.